Reversal of neuropathic pain by alpha-hydroxyphenylamide: a novel sodium channel antagonist |
| |
Authors: | Ko Seong-Hoon Jochnowitz Nina Lenkowski Paul W Batts Timothy W Davis Gary C Martin William J Brown Milton L Patel Manoj K |
| |
Affiliation: | Department of Anesthesiology, University of Virginia Health System, 1 Hospital Drive, Box 800710, Charlottesville, VA 22908-0710, USA. |
| |
Abstract: | Sodium (Na) channel blockers are known to possess antihyperalgesic properties. We have designed and synthesized a novel Na channel antagonist, alpha-hydroxyphenylamide, and determined its ability to inhibit both TTX-sensitive (TTX-s) and TTX-resistant (TTX-r) Na currents from small dorsal root ganglion (DRG) neurons. alpha-Hydroxyphenylamide tonically inhibited both TTX-s and TTX-r Na currents yielding an IC(50) of 8.2+/-2.2 microM (n=7) and 28.9+/-1.8 microM (n=8), respectively. In comparison, phenytoin was less potent inhibiting TTX-s and TTX-r currents by 26.2+/-4.0% (n=8) and 25.5+/-2.0%, respectively, at 100 microM. alpha-Hydroxyphenylamide (10 microM) also shifted equilibrium gating parameters of TTX-s Na channels to greater hyperpolarized potentials, slowed recovery from inactivation, accelerated the development of inactivation and exhibited use-dependent block. In the chronic constriction injury (CCI) rat model of neuropathic pain, intraperitoneal administration of alpha-hydroxyphenylamide attenuated the hyperalgesia by 53% at 100mg/kg, without affecting motor coordination in the Rotorod test. By contrast, the reduction in pain behavior produced by phenytoin (73%; 100mg/kg) was associated with significant motor impairment. In summary, we report that alpha-hydroxyphenylamide, a sodium channel antagonist, exhibits antihyperalgesic properties in a rat model of neuropathic pain, with favorable sedative and ataxic side effects compared with phenytoin. |
| |
Keywords: | Electrophysiology Dorsal root ganglion neurons Sodium channels Phenytoin Neuropathic pain |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|